ABH Optics, a Copenhagen-based eyeglass lens manufacturer, has successfully raised €1 million in Pre-Seed funding. The company’s innovative approach in using nanotechnology to develop thinner and more cost-efficient lenses has garnered interest from investors. The lenses not only cater to high prescription needs but also emphasize sustainability by reducing plastic usage.
ABH Optics’ recent funding round reflects growing investor confidence in the use of nanotechnology within the optical industry. Similar ventures have gained attention for their potential to revolutionize traditional lens manufacturing methods. ABH Optics’ focus on ultra-thin lenses for high prescriptions distinguishes it from earlier technological advancements seen in other companies, which often targeted broader applications with varying degrees of success. Recent trends indicate a shift towards more specialized and sustainable solutions, aligning with ABH Optics’ mission.
Innovative Lens Technology
Founded in 2022, ABH Optics has designed eyeglass lenses that are both lightweight and environmentally friendly. Their proprietary technology allows for customization in both optical power and structural integrity, catering to a niche market of eyeglass wearers with prescriptions over +/- 4 diopters. The lenses, which can accommodate prescriptions up to +/- 20 diopters, are less than 2 mm thick, offering unprecedented comfort and aesthetic appeal.
The company’s innovative lenses address a significant pain point for individuals with high dioptre prescriptions, making thick, cumbersome lenses a thing of the past. This development paves the way for more streamlined and comfortable eyewear, potentially setting a new standard within the industry. The emphasis on reducing plastic usage also resonates with the increasing consumer demand for sustainable products.
Significant Milestone
The funding round was led by High-Tech Gründerfonds (HTGF). Olaf Joeressen, Senior Investment Manager at HTGF, expressed optimism about the collaboration, highlighting the disruptive potential of ABH Optics’ technology in the eyeglass lenses market.
“We are excited to support ABH Optics in their journey to disrupt the eyeglass lenses market with meta-optics.”
“Their innovative approach to lens manufacturing has the potential to significantly improve the quality of life for individuals with high dioptre prescriptions, and we see a bright future for their technology in the market.”
Bo Svarrer Hansen, CEO of ABH Optics, emphasized the importance of this funding milestone for the company’s growth and market entry. The support from HTGF is seen as a pivotal step in bringing their advanced lenses to consumers, furthering their commitment to both innovation and sustainability.
“This funding marks a significant milestone for ABH Optics. We are thrilled to have the support of HTGF as we strive to bring our innovative lenses to the market.”
“Our technology not only enhances the comfort and aesthetics for those with high prescriptions but also aligns with our commitment to sustainability.”
This financial boost will enable ABH Optics to accelerate the development and commercialization of their advanced eyeglass lenses, ensuring that high-quality, sustainable optical solutions become more accessible to those in need.
ABH Optics, with its cutting-edge nanotechnology lenses, is poised to make a significant impact on the eyeglass industry. The successful funding round, led by HTGF, underscores the market’s recognition of the potential in ABH Optics’ innovative approach. The company’s dedication to providing high prescription solutions that are both efficient and environmentally friendly sets a promising precedent for future developments in optical technology.
